Semler Scientific Share Price (NASDAQ: SMLR)

$29.59

▲

-1.04

(-3.4%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Semler Scientific Stock chart to analyse performance

Semler Scientific stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$29.39
Today's High:$30.25
$29.59
0.68%
Downside
Day's Volatility :2.84%
Upside
2.18%
52 Weeks Low:$21.77
52 Weeks High:$81.56
$29.59
26.43%
Downside
52 Weeks Volatility :73.31%
Upside
63.72%

Semler Scientific Stock Returns

Period	Semler Scientific Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-16.66%	3.6%	0.0%
6 Months	-23.73%	-7.7%	0.0%
1 Year	20.47%	-12.6%	0.0%
3 Years	-33.57%	9.5%	-4.7%

Semler Scientific Inc Key Stats

Check Semler Scientific key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$30.63
Open	$30.25
Today's High	$30.25
Today's Low	$29.39
Market Capitalization	$453.5M
Today's Volume	$483.4K
52 Week High	$81.5551
52 Week Low	$21.77
Revenue TTM	$43.0M
EBITDA	$5.4M
Earnings Per Share (EPS)	$4.57
PE Ratio	6.7
Profit Margin	86.2%
Quarterly Earnings Growth YOY	3570.09%
Return On Equity TTM	16.04%

Stock Returns calculator for Semler Scientific Stock including INR - Dollar returns

The Semler Scientific stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Semler Scientific investment value today

Current value as on today

₹1,16,108

Returns

₹16,108

(+16.11%)

Returns from Semler Scientific Stock

₹10,824 (+10.82%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Semler Scientific Stock

26%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Semler Scientific Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Semler Scientific Inc

Name
Holdings %
Name
Holdings %
Interchange Capital Partners, LLC
8.68%
Morgan Stanley - Brokerage Accounts
4.98%
Capital Research & Mgmt Co - Division 3
4.71%
Vanguard Group Inc
4.32%
BlackRock Inc
3.37%
Driehaus Capital Management LLC
1.26%

Analyst Recommendation on Semler Scientific Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Semler Scientific(by analysts ranked 0 to 5 stars)

Semler Scientific Share Price Target

What analysts predicted

Upside of 188.39%

Target:

$85.33

Current:

$29.59

Semler Scientific share price target is $85.33, a slight Upside of 188.39% compared to current price of $29.59 as per analysts' prediction.

Semler Scientific Stock Insights

Price Movement
In the last 1 month, SMLR stock has moved down by -17.4%
Decreasing Revenue
Revenue is down for the last 6 quarters, 15.90M → 8.21M (in $), with an average decrease of 11.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -64.70M → 66.93M (in $), with an average increase of 196.7% per quarter
SMLR vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 17.9%
SMLR vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 196.6%
Price to Sales
ForSMLR every $1 of sales, investors are willing to pay $6.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Semler Scientific Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$32.8M	↑ 52.47%
Net Income	$15.1M	↑ 200.84%
Net Profit Margin	46.03%	↑ 22.7%

	FY20	Y/Y Change
Revenue	$38.6M	↑ 17.81%
Net Income	$14.0M	↓ 7.14%
Net Profit Margin	36.28%	↓ 9.75%

	FY21	Y/Y Change
Revenue	$53.0M	↑ 37.36%
Net Income	$17.2M	↑ 22.95%
Net Profit Margin	32.48%	↓ 3.8%

	FY22	Y/Y Change
Revenue	$56.7M	↑ 6.9%
Net Income	$14.3M	↓ 16.82%
Net Profit Margin	25.27%	↓ 7.21%

	FY23	Y/Y Change
Revenue	$68.2M	↑ 20.28%
Net Income	$20.6M	↑ 43.69%
Net Profit Margin	30.19%	↑ 4.92%

	FY24	Y/Y Change
Revenue	$56.3M	↓ 17.44%
Net Income	$40.9M	↑ 98.7%
Net Profit Margin	72.65%	↑ 42.46%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$15.9M	↑ 5.63%
Net Income	$6.1M	↑ 43.88%
Net Profit Margin	38.19%	↑ 10.15%

	Q2 FY24	Q/Q Change
Revenue	$14.5M	↓ 9.04%
Net Income	$11.0K	↓ 99.82%
Net Profit Margin	0.08%	↓ 38.11%

	Q3 FY24	Q/Q Change
Revenue	$13.5M	↓ 6.59%
Net Income	$5.6M	↑ 50890.91%
Net Profit Margin	41.51%	↑ 41.43%

	Q4 FY24	Q/Q Change
Revenue	$12.4M	↓ 8.13%
Net Income	$29.2M	↑ 420.7%
Net Profit Margin	235.29%	↑ 193.78%

	Q1 FY25	Q/Q Change
Revenue	$8.8M	↓ 28.82%
Net Income	$-64.7M	↓ 321.54%
Net Profit Margin	-732.34%	↓ 967.63%

	Q2 FY25	Q/Q Change
Revenue	$8.2M	↓ 6.99%
Net Income	$66.9M	↓ 203.45%
Net Profit Margin	814.57%	↑ 1546.91%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$29.1M	↑ 54.92%

	FY20	Y/Y Change
Profit	$35.2M	↑ 21.1%

	FY21	Y/Y Change
Profit	$46.9M	↑ 33.08%

	FY22	Y/Y Change
Profit	$52.4M	↑ 11.79%

	FY23	Y/Y Change
Profit	$61.2M	↑ 16.72%

	FY24	Y/Y Change
Profit	$51.5M	↓ 15.79%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$14.7M	↑ 25.57%

	Q2 FY24	Q/Q Change
Profit	$13.2M	↓ 9.87%

	Q3 FY24	Q/Q Change
Profit	$12.4M	↓ 6.46%

	Q4 FY24	Q/Q Change
Profit	$11.3M	↓ 8.46%

	Q1 FY25	Q/Q Change
Profit	$7.9M	↓ 30.17%

	Q2 FY25	Q/Q Change
Profit	$7.5M	↓ 5.32%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$12.7M	↑ 170.98%
Investing Cash Flow	$-1.7M	↑ 101.42%
Financing Cash Flow	$-6.6M	↑ 224.27%

	FY20	Y/Y Change
Operating Cash Flow	$15.4M	↑ 21.13%
Investing Cash Flow	$-1.3M	↓ 22.91%
Financing Cash Flow	$230.0K	↓ 103.5%

	FY21	Y/Y Change
Operating Cash Flow	$16.1M	↑ 4.14%
Investing Cash Flow	$-825.0K	↓ 36.97%
Financing Cash Flow	$13.0K	↓ 94.35%

	FY22	Y/Y Change
Operating Cash Flow	$17.5M	↑ 8.76%
Investing Cash Flow	$-26.8M	↑ 3152.73%
Financing Cash Flow	$-4.9M	↓ 38076.92%

	FY23	Y/Y Change
Operating Cash Flow	$21.3M	↑ 22.14%
Investing Cash Flow	$18.4M	↓ 168.55%
Financing Cash Flow	$-5.4M	↑ 9.54%

	FY24	Y/Y Change
Operating Cash Flow	$24.4M	↑ 14.44%
Investing Cash Flow	$-190.0M	↓ 1132.74%
Financing Cash Flow	$117.2M	↓ 2267.01%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$5.6M	↑ 503.43%
Investing Cash Flow	$-81.0K	↓ 100.43%
Financing Cash Flow	$11.0K	↓ 100.34%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$4.9M	↓ 12.27%
Investing Cash Flow	$-60.5M	↑ 74550.62%
Financing Cash Flow	$111.0K	↑ 909.09%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$6.4M	↑ 30.22%
Investing Cash Flow	$-8.4M	↓ 86.05%
Financing Cash Flow	$1.2M	↑ 1023.42%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$7.4M	↑ 15.6%
Investing Cash Flow	$-121.0M	↑ 1334.49%
Financing Cash Flow	$115.8M	↑ 9188.13%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-1.9M	↓ 125.66%
Investing Cash Flow	$-87.3M	↓ 27.84%
Financing Cash Flow	$90.1M	↓ 22.18%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$514.0K	↓ 126.97%
Investing Cash Flow	$-149.7M	↑ 71.42%
Financing Cash Flow	$152.9M	↑ 69.63%

Semler Scientific Technicals Summary

Sell

Neutral

Buy

Semler Scientific is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Semler Scientific Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Semler Scientific Inc	-17.27%	-23.73%	20.47%	-33.57%	-76.65%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Semler Scientific Inc	6.7	6.7	0.0	-2.78	0.16	0.01	NA	28.01
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Semler Scientific Inc	Buy	$453.5M	-76.65%	6.7	86.2%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Semler Scientific Inc

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Organization	Semler Scientific
Employees	79
CEO	Dr. Douglas Murphy-Chutorian M.D.
Industry	Medical Specialties

Key Management of Semler Scientific Inc

Name	Title
Mr. Eric H. Semler	Executive Chairman of the Board
Dr. Douglas Murphy-Chutorian M.D.	CEO, President & Director
Ms. Renae Cormier	CFO, Head of Corp. Communications & Bus. Strategy and Secretary
Dr. Herbert J. Semler F.A.C.C., F.A.C.P, F.A.H., F.S.C.A.I., J.S., M.D.	Founder & Chairman Emeritus
Mr. Shane Reid	Chief Technology Officer
Ms. Cindy Guinasso	Senior Vice President of Business Development
Joe Burnett	Director of Bitcoin Strategy

Important FAQs about investing in SMLR Stock from India :

What is Semler Scientific share price today?

Semler Scientific share price today is $29.59 as on August 30, 2025 at 1:29 am IST at the close of the market. Semler Scientific share today touched a day high of $30.25 and a low of $29.39.

What is the 52 week high and 52 week low for Semler Scientific share?

Semler Scientific share touched a 52 week high of $81.56 and a 52 week low of $21.77. Semler Scientific stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $29.59, lower by 63.72% versus the 52 week high.

How to invest in Semler Scientific Stock (SMLR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Semler Scientific on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Semler Scientific Shares that will get you 0.0507 shares as per Semler Scientific share price of $29.59 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Semler Scientific Stock (SMLR) from India?

Indian investors can start investing in Semler Scientific (SMLR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Semler Scientific stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Semler Scientific share’s latest price of $29.59 as on August 30, 2025 at 1:29 am IST, you will get 0.3380 shares of Semler Scientific. Learn more about fractional shares .

What are the returns that Semler Scientific has given to Indian investors in the last 5 years?

Semler Scientific stock has given -76.65% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?